KR102340504B1 - 신경계 질환의 영상화 - Google Patents
신경계 질환의 영상화 Download PDFInfo
- Publication number
- KR102340504B1 KR102340504B1 KR1020167001611A KR20167001611A KR102340504B1 KR 102340504 B1 KR102340504 B1 KR 102340504B1 KR 1020167001611 A KR1020167001611 A KR 1020167001611A KR 20167001611 A KR20167001611 A KR 20167001611A KR 102340504 B1 KR102340504 B1 KR 102340504B1
- Authority
- KR
- South Korea
- Prior art keywords
- imaging
- ratio
- radiopharmaceutical
- normal
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CN(C(CC1)C2)C1[C@](*)[C@@]2c1ccc(*)cc1 Chemical compound CN(C(CC1)C2)C1[C@](*)[C@@]2c1ccc(*)cc1 0.000 description 4
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Neurosurgery (AREA)
- Dentistry (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nuclear Medicine (AREA)
- Pulmonology (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1313291.5A GB201313291D0 (en) | 2013-07-25 | 2013-07-25 | Imaging neurological disease |
| GB1313291.5 | 2013-07-25 | ||
| PCT/EP2014/066042 WO2015011267A1 (en) | 2013-07-25 | 2014-07-25 | Imaging neurological disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20160037168A KR20160037168A (ko) | 2016-04-05 |
| KR102340504B1 true KR102340504B1 (ko) | 2021-12-20 |
Family
ID=49166921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020167001611A Active KR102340504B1 (ko) | 2013-07-25 | 2014-07-25 | 신경계 질환의 영상화 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11051777B2 (enExample) |
| EP (1) | EP3024501B1 (enExample) |
| JP (1) | JP6590801B2 (enExample) |
| KR (1) | KR102340504B1 (enExample) |
| CN (1) | CN105392500B (enExample) |
| AU (2) | AU2014294983B2 (enExample) |
| BR (1) | BR112016001316B1 (enExample) |
| CA (1) | CA2916125A1 (enExample) |
| DK (1) | DK3024501T3 (enExample) |
| ES (1) | ES2722973T3 (enExample) |
| GB (1) | GB201313291D0 (enExample) |
| IL (1) | IL243383B (enExample) |
| MX (1) | MX2016001012A (enExample) |
| RU (1) | RU2015155792A (enExample) |
| SG (1) | SG11201600571RA (enExample) |
| WO (1) | WO2015011267A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104720840A (zh) * | 2015-02-11 | 2015-06-24 | 清华大学深圳研究生院 | 基于多巴胺转运体显像特异性摄取比的半自动量化方法 |
| TWI587841B (zh) * | 2015-03-06 | 2017-06-21 | 國立陽明大學 | 定量分析核子醫學腦部影像的系統及方法 |
| US20180000440A1 (en) * | 2015-03-24 | 2018-01-04 | Nihon Medi-Physics Co., Ltd. | Image processing apparatus, image processing method, and program |
| KR101720288B1 (ko) | 2016-05-11 | 2017-03-28 | (주)바이오액츠 | 뇌 영상용 염료 및 이의 제조방법 |
| JP6549521B2 (ja) * | 2016-05-25 | 2019-07-24 | 富士フイルム富山化学株式会社 | 疾患鑑別支援装置及びコンピュータプログラム |
| TWI607739B (zh) * | 2016-05-27 | 2017-12-11 | 許百靈 | Spect多巴胺顯像定量分析技術與在腦多巴胺評估的用途 |
| GB201621698D0 (en) * | 2016-12-20 | 2017-02-01 | Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center | Differential Diagnosis |
| JP6995642B2 (ja) * | 2018-01-19 | 2022-01-14 | 日本メジフィジックス株式会社 | 画像処理装置、画像処理方法およびプログラム |
| TWI686178B (zh) * | 2019-10-09 | 2020-03-01 | 中原大學 | 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統 |
| US20230001026A1 (en) * | 2019-11-21 | 2023-01-05 | Likeminds, Inc. | Pharmaceutical packaging units and methods for concomitant administration of radiotracers |
| AR125188A1 (es) | 2021-03-22 | 2023-06-21 | Neurocrine Biosciences Inc | Inhibidores del vmat2 y métodos de uso |
| CN119599879B (zh) * | 2024-11-06 | 2025-10-24 | 复旦大学附属华山医院 | 一种基于深度学习的pet图像跨膜态合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009040727A2 (en) * | 2007-09-26 | 2009-04-02 | Philips Intellectual Property & Standards Gmbh | Method of differentially diagnosing different types of dementia |
| US8084018B2 (en) * | 2007-10-31 | 2011-12-27 | Alseres Pharmaceuticals, Inc. | Methods for imaging dopamine transporter level |
| US20100312105A1 (en) * | 2007-10-31 | 2010-12-09 | Alseres Pharmaceuticals, Inc. | Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
-
2013
- 2013-07-25 GB GBGB1313291.5A patent/GB201313291D0/en not_active Ceased
-
2014
- 2014-07-25 BR BR112016001316-6A patent/BR112016001316B1/pt active IP Right Grant
- 2014-07-25 CN CN201480041743.1A patent/CN105392500B/zh active Active
- 2014-07-25 WO PCT/EP2014/066042 patent/WO2015011267A1/en not_active Ceased
- 2014-07-25 DK DK14742544.1T patent/DK3024501T3/da active
- 2014-07-25 KR KR1020167001611A patent/KR102340504B1/ko active Active
- 2014-07-25 JP JP2016528546A patent/JP6590801B2/ja active Active
- 2014-07-25 RU RU2015155792A patent/RU2015155792A/ru unknown
- 2014-07-25 US US14/907,428 patent/US11051777B2/en active Active
- 2014-07-25 MX MX2016001012A patent/MX2016001012A/es unknown
- 2014-07-25 SG SG11201600571RA patent/SG11201600571RA/en unknown
- 2014-07-25 EP EP14742544.1A patent/EP3024501B1/en active Active
- 2014-07-25 CA CA2916125A patent/CA2916125A1/en not_active Abandoned
- 2014-07-25 AU AU2014294983A patent/AU2014294983B2/en active Active
- 2014-07-25 ES ES14742544T patent/ES2722973T3/es active Active
-
2015
- 2015-12-28 IL IL243383A patent/IL243383B/en active IP Right Grant
-
2019
- 2019-10-23 AU AU2019253837A patent/AU2019253837B2/en active Active
Non-Patent Citations (3)
| Title |
|---|
| J P SEIBYL 외. Annals of Neurology. Vol. 38(4), pp. 589-598 |
| MEI-CHUN HSIAO 외.Schizophrenia Research. Vol. 65(1), pp.39-46 |
| REGINA KATZENSCHNAGER 외. Annals of Neurology. Vol. 53(4), pp.489-496 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105392500B (zh) | 2023-08-18 |
| WO2015011267A1 (en) | 2015-01-29 |
| IL243383B (en) | 2018-07-31 |
| RU2015155792A3 (enExample) | 2018-05-23 |
| CA2916125A1 (en) | 2015-01-29 |
| US11051777B2 (en) | 2021-07-06 |
| GB201313291D0 (en) | 2013-09-11 |
| AU2014294983A1 (en) | 2016-01-21 |
| RU2015155792A (ru) | 2017-08-30 |
| JP6590801B2 (ja) | 2019-10-16 |
| HK1222118A1 (zh) | 2017-06-23 |
| ES2722973T3 (es) | 2019-08-20 |
| EP3024501A1 (en) | 2016-06-01 |
| KR20160037168A (ko) | 2016-04-05 |
| EP3024501B1 (en) | 2019-03-27 |
| DK3024501T3 (da) | 2019-05-06 |
| BR112016001316B1 (pt) | 2021-04-06 |
| US20160183897A1 (en) | 2016-06-30 |
| SG11201600571RA (en) | 2016-02-26 |
| JP2016531903A (ja) | 2016-10-13 |
| AU2014294983B2 (en) | 2019-10-24 |
| AU2019253837A1 (en) | 2019-11-14 |
| AU2019253837B2 (en) | 2021-11-25 |
| CN105392500A (zh) | 2016-03-09 |
| MX2016001012A (es) | 2016-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102340504B1 (ko) | 신경계 질환의 영상화 | |
| Guedj et al. | EANM procedure guidelines for brain PET imaging using [18F] FDG, version 3 | |
| Villemagne et al. | In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease | |
| Politis et al. | Positron emission tomography imaging in neurological disorders | |
| Park et al. | 11C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas | |
| Riccardi et al. | Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans | |
| Henry et al. | In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy | |
| US10650519B2 (en) | Voxel-based methods for assessing subjects using magnetic resonance imaging | |
| Masterman et al. | Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias | |
| Nocker et al. | Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I] β-CIT SPECT | |
| Koeppe et al. | Differentiating Alzheimer’s disease from dementia with Lewy bodies and Parkinson’s disease with (+)-[11C] dihydrotetrabenazine positron emission tomography | |
| Henderson | The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging | |
| Hsiao et al. | Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients | |
| Molina et al. | Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity | |
| JP2014148529A (ja) | ドーパミン輸送体レベルを造影するための方法 | |
| JP2011502966A5 (enExample) | ||
| JP2011502966A (ja) | ドーパミントランスポーターレベルを評価することによるレビー小体型認知症の診断およびレビー小体型認知症の処置のモニタリングのための方法 | |
| Romano et al. | Florbetapir F 18 for brain imaging of beta-amyloid plaques | |
| Varrone et al. | Molecular imaging of neuroinflammation in Alzheimer’s disease | |
| Booij et al. | Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible | |
| Edison et al. | Strategies for the generation of parametric images of [11C] PIB with plasma input functions considering discriminations and reproducibility | |
| Huang et al. | Chronic manganism: a long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan | |
| HK1222118B (zh) | 成像神经学疾病 | |
| Niethammer et al. | PET and SPECT Imaging in Atypical Parkinsonian Syndromes | |
| Khattar et al. | Optimized reference region and the effect on test-retest reliability and detection of Parkinson’s disease with [11C] UCB-J |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20160120 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| AMND | Amendment | ||
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20190625 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200810 Patent event code: PE09021S01D |
|
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20210222 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20200810 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| X091 | Application refused [patent] | ||
| AMND | Amendment | ||
| PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20210222 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20201012 Comment text: Amendment to Specification, etc. Patent event code: PX09012R01I Patent event date: 20160226 Comment text: Amendment to Specification, etc. |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210526 Patent event code: PE09021S01D |
|
| AMND | Amendment | ||
| PX0701 | Decision of registration after re-examination |
Patent event date: 20211123 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20210721 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20210426 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20210222 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20201012 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20160226 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20211214 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20211215 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |